Guideline for radioimmunotherapy of CD20+ follicular B-cell non-Hodgkin's lymphoma

被引:3
作者
Fischer, M. [1 ]
Gruenwald, F. [1 ]
Knapp, W. H. [1 ]
Truemper, L. [2 ]
von Schilling, C. [2 ]
Dreyling, M. [2 ]
机构
[1] Deutsch Gesell Nukl Med, Kassel, Germany
[2] Deutsch Gesell Hamatol & Onkol, Kassel, Germany
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2009年 / 48卷 / 06期
关键词
Radioimmunotherapy; Zevalin; non-Hodgkin lymphoma; CD20-receptors; yttrium-90; IBRITUMOMAB TIUXETAN; WORKSHOP; IMMUNOTHERAPY; TRIAL;
D O I
10.3413/nukmed-0318
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This guideline is a prerequisite for the quality management in the treatment of non-Hodgkon-lymphomas in patients with relapsed or refractory follicular lymphoma after rituximab therapy and as consolidation therapy after first remission following CHOP like treatment using radioimmunotherapy. It is based on an interdisciplinary consensus and contains background information and definitions as well as specified indications and detailed contraindications of treatment. Essential topics are the requirements for institutions performing the therapy. For instance, presence of an expert for medical physics, intense cooperation with all colleagues committed to treatment of lymphomas, and a certificate of instruction in radiochemical labelling and quality control are required. Furthermore, it is specified which patient data have to be available prior to performance of therapy and how treatment has to be carried out technically. Here, quality control and documentation of labelling are of great importance. After treatment, clinical quality control is mandatory (work-up of therapy data and follow-up of patients). Essential elements of follow-up are specified in detail. The complete treatment inclusive after-care has to be realised in close cooperation with those colleagues (hemato-oncologists) who propose, in general, radioimmunotherapy under consideration of the development of the disease.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 9 条
[1]   Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].
Cheson, BD ;
Horning, SJ ;
Coiffier, B ;
Shipp, MA ;
Fisher, RI ;
Connors, JM ;
Lister, TA ;
Vose, J ;
Grillo-López, A ;
Hagenbeek, A ;
Cabanillas, F ;
Klippensten, D ;
Hiddemann, W ;
Castellino, R ;
Harris, NL ;
Armitage, JO ;
Carter, W ;
Hoppe, R ;
Canellos, GP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253
[2]   Results of a national consensus workshop:: therapeutic algorithm in patients with follicular lymphoma -: role of radioimmunotherapy [J].
Dreyling, M. ;
Truemper, L. ;
von Schilling, C. ;
Rummel, M. ;
Holtkamp, U. ;
Waldmann, A. ;
Wehmeyer, J. ;
Freund, M. .
ANNALS OF HEMATOLOGY, 2007, 86 (02) :81-87
[3]   Phase III Trial of Consolidation Therapy With Yttrium-90-Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma [J].
Morschhauser, Franck ;
Radford, John ;
Van Hoof, Achiel ;
Vitolo, Umberto ;
Soubeyran, Pierre ;
Tilly, Herve ;
Huijgens, Peter C. ;
Kolstad, Arne ;
d'Amore, Francesco ;
Diaz, Marcos Gonzalez ;
Petrini, Mario ;
Sebban, Catherine ;
Zinzani, Pier Luigi ;
van Oers, Marinus H. J. ;
van Putten, Wim ;
Bischof-Delaloye, Angelika ;
Rohatiner, Ama ;
Salles, Gilles ;
Kuhlmann, Jens ;
Hagenbeek, Anton .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) :5156-5164
[4]   Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphorna not appropriate for autologous stem-cell transplantation [J].
Morschhauser, Franck ;
Illidge, Tim ;
Huglo, Damien ;
Martinelli, Giovanni ;
Paganelli, Giovanni ;
Zinzani, Pier Luigi ;
Rule, Simon ;
Liberati, Anna Marina ;
Milpied, Noel ;
Hess, Georg ;
Stein, Harald ;
Kalmus, Joachim ;
Marcus, Robert .
BLOOD, 2007, 110 (01) :54-58
[5]   Radioimmunotherapy in relapsed follicular lymphoma previously treated by autologous bone marrow transplant: a report of eight new cases and literature review [J].
Peyrade, Frederic ;
Triby, Caroline ;
Slama, Bohane ;
Fontana, Xavier ;
Gressin, Remy ;
Broglia, Jean-Marc ;
Lepeu, Gerard ;
Carrier, Patricia ;
Peyrottes, Isabelle ;
Darcourt, Jacques ;
Bondiau, Pierre-Yves ;
Thyss, Antoine .
LEUKEMIA & LYMPHOMA, 2008, 49 (09) :1762-1768
[6]   Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma [J].
Witzig, TE ;
Gordon, LI ;
Cabanillas, F ;
Czuczman, MS ;
Emmanouilides, C ;
Joyce, R ;
Pohlman, BL ;
Bartlett, NL ;
Wiseman, GA ;
Padre, N ;
Grillo-López, AJ ;
Multani, P ;
White, CA .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2453-2463
[7]   Long-term responses in patients with recurring or refractory B-Ccll non-hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan [J].
Witzig, Thomas E. ;
Molina, Arturo ;
Gordon, Leo I. ;
Emmanouilides, Christos ;
Schilder, Russell J. ;
Flinn, Ian W. ;
Darif, Mohamed ;
Macklis, Roger ;
Vo, Katie ;
Wiseman, Gregory A. .
CANCER, 2007, 109 (09) :1804-1810
[8]   Fludarabine and mitoxantrone followed by yttrium-9 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ) [J].
Zinzani, Pier Luigi ;
Tani, Monica ;
Pulsoni, Alessandro ;
Gobbi, Marco ;
Perotti, Alessio ;
De Luca, Stefano ;
Fabbri, Alberto ;
Zaccaria, Alfonso ;
Voso, Maria Teresa ;
Fattori, Pierpaolo ;
Guardigni, Luciano ;
Ronconi, Sonia ;
Cabras, Maria Giuseppina ;
Rigacci, Luigi ;
De Renzo, Arnalia ;
Marchi, Enrica ;
Stefoni, Vittorio ;
Fina, Mariapaola ;
Pellegrini, Cinzia ;
Musuraca, Gerardo ;
Derenzini, Enrico ;
Pileri, Stefano ;
Fanti, Stefano ;
Piccaluga, Pier Paolo ;
Baccarani, Michele .
LANCET ONCOLOGY, 2008, 9 (04) :352-358
[9]   Consensus conference: Implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - Report of a European workshop [J].
Zinzani, Pier Luigi ;
d'Amore, Francesco ;
Bombardieri, Emilio ;
Brammer, Caroline ;
Codina, Jose Gomez ;
Illidge, Tim ;
Jurczak, Wojciech ;
Linkesch, Werner ;
Morschhauser, Franck ;
Vandenberghe, Elisabeth ;
Van Hoof, Achiel .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (03) :366-373